Dennis W Wester

Title: The Innovations of Dennis W Wester

Introduction

Dennis W Wester is an accomplished inventor based in Lynnwood, WA (US). He has made significant contributions to the field of protein derivatization, particularly in the context of targeting proteins with radionuclides. His innovative approach has implications for various applications in medical and scientific research.

Latest Patents

Wester holds a patent for a process titled "Minimal derivatization of proteins." This patent describes a method for minimally derivatizing a targeting protein with a radionuclide. The predominant species of the derivatized targeting protein contains one radionuclide group as a single radiolabeled ligand. Importantly, this process ensures that the binding characteristics of the targeting protein are minimally affected. Additionally, the patent discloses ligands that can chelate a metal radionuclide or bind a halogen radionuclide while providing a means for separating radiolabeled ligand from unradiolabeled ligand. Wester's innovative work in this area has the potential to enhance the effectiveness of targeted therapies.

Career Highlights

Dennis W Wester is associated with Neorx Corporation, where he continues to advance his research and development efforts. His work at Neorx Corporation has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Alan R Fritzberg and Daniel S Wilbur. Their collective expertise contributes to the innovative environment at Neorx Corporation.

Conclusion

Dennis W Wester's contributions to the field of protein derivatization and radionuclide targeting represent a significant advancement in scientific research. His patent and ongoing work at Neorx Corporation highlight his commitment to innovation and collaboration in the pursuit of new solutions.